Tag

Bristol-Myers Squibb

mergers & acquisitions

Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics
handshake

Bristol Myers Squibb Acquires RayzeBio for $4.1B
Brain

BMS Strengthens Neuroscience Portfolio with Karuna Acquisition
SciTech Scity

BMS Joins SciTech Scity as Healthcare Innovation Lead Partner
Christopher Boerner

Bristol Myers Squibb Appoints Boerner CEO & Chairperson
M&A

Bristol Myers Squibb to Acquire Mirati in a $4.8B Deal
Diversity

BMS Enters the Billion Dollar Roundtable, Expands Supplier Diversity Efforts
diversity

BMS Makes Progress Toward Long-Term DEI and Health Equity Goals
clinical trial

BMS Launches Disability Diversity in Clinical Trials Initiative
BMS riders

Bristol Myers Squibb Employees Pedal Across the US to Advance Cancer Research
Black Woman

BMS, Black Higher Ed Institutions Help Get Black Talent in Biopharma
green energy

BMS Strengthens Commitment to Environment
handshake

BMS to Acquire MyoKardia for $13.1B
healthcare

BMS Commits $300M to Health Equity and Diversity and Inclusion Efforts
diversity

Fostering Diversity and Inclusion
Coronavirus

Bristol Myers Squibb Expands Patient Support Programs
lease

NJEDA on PTC Therapeutics’ Expansion
Digital

Celgene Stockholders Move on BMS Deal
healthcare tech

BMS to Collaborate with Janssen on Cardiovascular Therapy
research & development

Bristol-Myers Squibb Strengthens Capabilities with Evolution of its US Geographic Footprint
MRI

Bristol-Myers Squibb Foundation Awards Eight Grants for Lung and Skin Cancer Screening
business people

Six NJ-based Companies Named Top Corporations for Women’s Business Enterprises by WBENC
healthcare vaccine

Bristol-Myers Squibb Receives Accelerated Approval of Opdivo (nivolumab) from the U.S. Food and Drug Administration